During the past decade, IRCCS E. Medea conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "IRCCS E. Medea" #1 collaborator was "National Research Council of Italy" with 2 trials as a collaborator, "Asociatia Bucuresti Pentru Copii Dislexici" with 1 trials as a collaborator, "Asur Marche - AV1 - Centre for Clinical Child Neuropsychology" with 1 trials as a collaborator, "Augumented Reality Software ARSOFT" with 1 trials as a collaborator and "CNR - ICMATE UOS di Lecco" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "IRCCS E. Medea" are "Acquired Brain Injury" (7 trials), "Parent-Child Relations" (4 trials), "Epigenetics" (3 trials), "Preterm Birth" (3 trials) and "Attention Deficit Hyperactivity Disorder" (2 trials). Many other conditions were trialed in "IRCCS E. Medea" in a lesser frequency.

Most popular intervention types in "IRCCS E. Medea" are "Device" (12 trials), "Diagnostic Test" (8 trials), "Behavioral" (4 trials), "Other" (4 trials) and "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "DNA methylation of target genes" (2 trials), "Teen On-line Problem Solving" (2 trials), "ABI ABC" (1 trials), "Ankle active and passive mobilization using an Ankle mobilization device" (1 trials) and "Augmented reality training" (1 trials). Other intervention names were less common.

The vast majority of trials in "IRCCS E. Medea" are 30 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "IRCCS E. Medea". undefined are not yet recruiting, 14 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in IRCCS E. Medea, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in IRCCS E. Medea, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 18 trials that are defined as “Not Applicable".